Drug Shortage Report for EPIPEN JR
| Report ID | 37657 |
| Drug Identification Number | 00578657 |
| Brand name | EPIPEN JR |
| Common or Proper name | EPIPEN JR |
| Company Name | MYLAN SPECIALTY LP |
| Market Status | MARKETED |
| Active Ingredient(s) | EPINEPHRINE |
| Strength(s) | 0.5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR |
| Packaging size | Each (0.15MG/0.3ML AUTO-INJECTOR) |
| ATC code | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2018-04-16 |
| Actual start date | 2018-04-16 |
| Estimated end date | |
| Actual end date | 2019-02-19 |
| Shortage status | Resolved |
| Updated date | 2019-02-20 |
| Company comments | |
| Health Canada comments | http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/67330a-eng.php |
| Tier 3 Status | No |
| Contact Address | 3711 COLLINS FERRY ROAD MORGANTOWN, WEST VIRGINIA UNITED STATES 26505 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.